Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02874534 · ClinicalTrials.gov registry record · NA
Development of a Novel Transdiagnostic Intervention for Anhedonia - R61 Phase
A NA study of Anhedonia, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT02874534 is a NA study of Anhedonia that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 57 participants, below the 108-participant average among 21 other Anhedonia trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02874534, a NA study of Anhedonia, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this project is to develop a novel transdiagnostic treatment for anhedonia, called Behavioral Activation Treatment for Anhedonia (BATA), using ultra-high field functional neuroimaging. There is a critical need for a validated treatment that specifically targets anhedonia, and this project will evaluate the effects of this new treatment on anhedonia and will establish how this treatment impacts brain systems that mediate reward processing, clinical symptoms of anhedonia, functional outcomes, and behavioral indices of reward processing. This work will also identify brain targets by which future novel anhedonia treatment may be evaluated.
Conditions Studied
Interventions
- BEHAVIORAL Behavioral Activation
- BEHAVIORAL Mindfulness Treatment
Study Locations (1)
North Carolina
- UNC Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2017-06-22 |
| Est. Completion | 2019-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02874534
The ClinicalTrials.gov registry entry for NCT02874534 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 108-participant average among 21 other Anhedonia trials with a reported enrollment target (47% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anhedonia appearing as the primary indexed condition, and to 2 interventions - of which Behavioral Activation is the first listed.
NCT02874534 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02874534 about?
NCT02874534 is a clinical study titled "Development of a Novel Transdiagnostic Intervention for Anhedonia - R61 Phase". The overall goal of this project is to develop a novel transdiagnostic treatment for anhedonia, called Behavioral Activation Treatment for Anhedonia (BATA), using ultra-high field functional neuroimaging. There is a critical need for a validated treatment that specifically targets anhedonia, and thi...
What is the current status of trial NCT02874534?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2017-06-22. Estimated completion is 2019-07-31.
What conditions does trial NCT02874534 study?
This clinical trial studies the following conditions: Anhedonia.
What interventions are being tested in trial NCT02874534?
The interventions under investigation include: Behavioral Activation (BEHAVIORAL), Mindfulness Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT02874534?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02874534 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anhedonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression
RECRUITING · NA
-
Get ActivE Study for At-risk Youth
RECRUITING · NA
-
Reward Processing and Exposure Therapy for Social Anxiety Disorder
RECRUITING · NA
-
Psychotherapy Effects on Reward Processing in PTSD
RECRUITING · NA
-
Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression
RECRUITING · NA
-
Geolocation Positional System (GPS) Experience
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.